Delivery Order SPE2DB22D3011-SPE2DB24FP9BN
Award Date
2/7/24
Potential Completion Date
2/8/24
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, was awarded a $4,000.87 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for NARCAN 4 MG NASAL SPRAY 2S. The $2,833.82 award has a completion date of February 21, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $18,070.67 for the supply of NARCAN 4 MG NASAL SPRAY 2S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 15, 2024. The contract is a firm fixed price arrangement with no set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $2,443.53 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY medical products. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide 4,563,782,408 units of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The $1,591.68 order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $5,285.68, has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $9,519.11 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of NARCAN 4 mg nasal spray to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $1,556.56, has an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price delivery order contract worth $2,051.89 for the supply of NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $5,761.76 firm fixed price delivery order contract to supply NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...